US Patent 7163948 Heterocyclic substituted 1,4-dihydri-4ox9-1,8-naphthyridine analogs
Patent 7163948 was granted and assigned to Cylene Pharmaceuticals on January, 2007 by the United States Patent and Trademark Office.
All edits
Edits on 6 Sep, 2023
Golden AI
Edits made to:
Infobox (+3 properties)
Infobox
Patent Inventor Names
Jeffrey P. Whitten0
Michael Schwaebe0
Terence Moran0
Edits on 31 Aug, 2023
Golden AI
Edits made to:
Article (+106 characters)
Article
Patent abstract
The present invention relates to 1,4-dihydro-4-oxo-1,8-napthpyridine analogs of the formula
Edits on 25 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 18 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07163948 Heterocyclic substituted 1,4-dihydri-4ox9-1,8-naphthyridine analogs US Patent 7163948 Heterocyclic substituted 1,4-dihydri-4ox9-1,8-naphthyridine analogs
Infobox
Patent Number
071639480
Patent Number
71639480
Edits on 24 Apr, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
071639480
Date of Patent
January 16, 2007
0Patent Application Number
108204870
Date Filed
April 7, 2004
0Official Website
Patent Primary Examiner
Edits on 8 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 20 Nov, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07163948 Heterocyclic substituted 1,4-dihydri-4ox9-1,8-naphthyridine analogs
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07163948
Date of patent
January 16, 2007
Patent application number
10820487
Date Filed
April 7, 2004
Patent primary examiner
Find more entities like US Patent 7163948 Heterocyclic substituted 1,4-dihydri-4ox9-1,8-naphthyridine analogs
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.